Immune-mediated necrotizing myopathy following vaccination with the AstraZeneca (AZD1222) COVID-19 vaccine: A case report and brief review

Immune-Mediated Necrotizing Myopathy (IMNM) after vaccination has been reported previously, however it is rare after COVID-19 vaccination. We report the first case of IMNM two weeks after vaccination with the AstraZeneca (AZD1222) COVID-19 vaccine. There was a probable temporal relationship between...

Descripción completa

Detalles Bibliográficos
Autores principales: Ansari, B., Najafi, M.A., Kheradmand, M., Najafi, F., Najafi, M.R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Masson SAS. 2023
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9889262/
https://www.ncbi.nlm.nih.gov/pubmed/36754672
http://dx.doi.org/10.1016/j.neurol.2022.11.009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9889262/
https://www.ncbi.nlm.nih.gov/pubmed/36754672
http://dx.doi.org/10.1016/j.neurol.2022.11.009

Ejemplares similares